248 related articles for article (PubMed ID: 30127499)
1. Screening for diabetes with HbA1c: Test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore.
Lim WY; Ma S; Heng D; Tai ES; Khoo CM; Loh TP
Sci Rep; 2018 Aug; 8(1):12419. PubMed ID: 30127499
[TBL] [Abstract][Full Text] [Related]
2. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
[TBL] [Abstract][Full Text] [Related]
3. Fasting Plasma Glucose and the HbA1c Are Not Optimal Screening Modalities for the Diagnosis of New Diabetes in Previously Undiagnosed Asian Indian Community Participants.
Prakaschandra R; Naidoo DP
Ethn Dis; 2018; 28(1):19-24. PubMed ID: 29467562
[TBL] [Abstract][Full Text] [Related]
4. Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV.
Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
BMJ Open; 2016 Dec; 6(12):e013835. PubMed ID: 27932342
[TBL] [Abstract][Full Text] [Related]
5. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.
Mannucci E; Ognibene A; Sposato I; Brogi M; Gallori G; Bardini G; Cremasco F; Messeri G; Rotella CM
Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278
[TBL] [Abstract][Full Text] [Related]
6. Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population.
Badings EA; Dyal L; Schoterman L; Lok DJ; Stoel I; Gerding MN; Gerstein HC; Tijssen JG
J Diabetes; 2011 Sep; 3(3):232-7. PubMed ID: 21631894
[TBL] [Abstract][Full Text] [Related]
7. [Cut-off points of fasting fingertip capillary blood glucose for detecting both undiagnosed diabetes and pre-diabetes].
Zhang YL; Guo SQ; Ma WB; Wang J; Bai GQ; Yang Q; Ti SF; Ma R; Wei RP; Liu WX; Li Z; Yang L; Liu DW; Li ZH
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Oct; 31(10):1174-8. PubMed ID: 21162825
[TBL] [Abstract][Full Text] [Related]
8. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
[TBL] [Abstract][Full Text] [Related]
9. HbA1c and the diagnosis of diabetes and prediabetes in a middle-aged and elderly Han population from northwest China (HbA1c).
Wu S; Yi F; Zhou C; Zhang M; Zhu Y; Tuniyazi Y; Huang L; Huang X; Wang F; Bi Y; Ning G
J Diabetes; 2013 Sep; 5(3):282-90. PubMed ID: 23452328
[TBL] [Abstract][Full Text] [Related]
10. Can HbA1c replace OGTT for the diagnosis of diabetes mellitus among Chinese patients with impaired fasting glucose?
Yu EY; Wong CK; Ho SY; Wong SY; Lam CL
Fam Pract; 2015 Dec; 32(6):631-8. PubMed ID: 26467644
[TBL] [Abstract][Full Text] [Related]
11. Optimal cut-off points of fasting plasma glucose for two-step strategy in estimating prevalence and screening undiagnosed diabetes and pre-diabetes in Harbin, China.
Bao C; Zhang D; Sun B; Lan L; Cui W; Xu G; Sui C; Wang Y; Zhao Y; Wang J; Li H
PLoS One; 2015; 10(3):e0119510. PubMed ID: 25785585
[TBL] [Abstract][Full Text] [Related]
12. Use of HbA1c for diagnoses of diabetes and prediabetes: comparison with diagnoses based on fasting and 2-hr glucose values and effects of gender, race, and age.
Guo F; Moellering DR; Garvey WT
Metab Syndr Relat Disord; 2014 Jun; 12(5):258-68. PubMed ID: 24512556
[TBL] [Abstract][Full Text] [Related]
13. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.
Valderhaug TG; Jenssen T; Hartmann A; Midtvedt K; Holdaas H; Reisaeter AV; Hjelmesaeth J
Transplantation; 2009 Aug; 88(3):429-34. PubMed ID: 19667949
[TBL] [Abstract][Full Text] [Related]
14. Glycated haemoglobin as a screening test for abnormal glucose homeostasis in childhood obesity.
Kumbhojkar A; Saraff V; Nightingale P; Högler W
Diabet Med; 2020 Feb; 37(2):356-361. PubMed ID: 31782826
[TBL] [Abstract][Full Text] [Related]
15. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.
Hage C; Lundman P; Rydén L; Mellbin L
Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695
[TBL] [Abstract][Full Text] [Related]
16. Alternative indices of glucose homeostasis as biochemical diagnostic tests for abnormal glucose tolerance in an African setting.
Kengne AP; Erasmus RT; Levitt NS; Matsha TE
Prim Care Diabetes; 2017 Apr; 11(2):119-131. PubMed ID: 28132763
[TBL] [Abstract][Full Text] [Related]
17. Using Serum Advanced Glycation End Products-Peptides to Improve the Efficacy of World Health Organization Fasting Plasma Glucose Criterion in Screening for Diabetes in High-Risk Chinese Subjects.
Sun Z; He J; Qiu S; Lei C; Zhou Y; Xie Z; Zhang L; Wang Y; Jin H
PLoS One; 2015; 10(9):e0137756. PubMed ID: 26368827
[TBL] [Abstract][Full Text] [Related]
18. Prediction of type 2 diabetes mellitus using fasting plasma glucose and HbA1c levels among individuals with impaired fasting plasma glucose: a cross-sectional study in Thailand.
Sitasuwan T; Lertwattanarak R
BMJ Open; 2020 Nov; 10(11):e041269. PubMed ID: 33172945
[TBL] [Abstract][Full Text] [Related]
19. Hemoglobin A1c in predicting progression to diabetes.
Nakagami T; Tajima N; Oizumi T; Karasawa S; Wada K; Kameda W; Susa S; Kato T; Daimon M
Diabetes Res Clin Pract; 2010 Jan; 87(1):126-31. PubMed ID: 19945760
[TBL] [Abstract][Full Text] [Related]
20. Ideal glycated hemoglobin cut-off points for screening diabetes and prediabetes in a Chinese population.
Liu Y; Xiao X; Sun C; Tian S; Sun Z; Gao Y; Li Y; Cheng J; Lv Y; Li M; Li Z; Zhang Y; Wang G; Liu Y; Gao Y; Zhu L; Liu Y; Wang G
J Diabetes Investig; 2016 Sep; 7(5):695-702. PubMed ID: 27181567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]